Navigation Links
MicroMass Promotes Kim Levy To Senior Vice President
Date:4/2/2009

CARY, N.C., April 2 /PRNewswire/ -- MicroMass Communications, Inc., a leader in behavioral science-based relationship marketing in the healthcare industry, has promoted Kim Levy to senior vice president. Located in the agency's Morristown, N.J. office, she will continue to provide strategic support to MicroMass clients, along with contributing to the agency's business development and marketing efforts.

She reports to Jay Bigelow, president.

Levy, 41, a veteran with more than a decade of experience on both the agency and client sides, has been responsible for medical marketing, promotion, managed care and CME. With wide-ranging category expertise, she has worked in oncology, psychiatry, women's health, urology, cardiovascular, pain management, ophthalmology, renal health and diagnostics/medical devices.

"Kim's management and category experience and her understanding of the behavioral drivers that generate adherence will be a major benefit to our growing list of clients," said Bigelow.

Prior to joining MicroMass in 2006, Levy spent three years as a medical education/marketing consultant for both pharma clients and agencies in the medical education arena, facilitating advisory boards, working with thought-leaders, developing marketing plans and creating strategies for managed care opinion leaders and supervising account teams.

Before that, she spent six years with Adair-Greene Healthcare Communications, an Atlanta-based healthcare agency, most recently as senior vice president, managing director, where she was responsible for the account services, creative and operational staff.

Levy started her career at Solvay Pharmaceuticals, a global pharmaceutical group based in Brussels, Belgium, where she worked out of the company's offices in Atlanta, Ga. from 1989 to 1997.

Levy holds a Masters of Science in health care management from Mercer University in Atlanta, Ga., and a Bachelor of Arts in Political Science from the University of California at Davis in Davis, Calif. She is member of the American College of Health Care Executives (ACHE). A frequent contributor to industry publications, she has also spoken at pharmaceutical marketing industry conferences. She lives in Chester, N.J.

About MicroMass Communications, Inc.

MicroMass personalizes brands. Founded in 1994, MicroMass is a relationship marketing agency with unrivalled capabilities in the use of behavioral science for gaining and applying deep consumer insights. The company's approach is founded on the belief that understanding the critical factors that influence individual behavior and creating a dialogue that addresses those factors is the best way of building enduring relationships between customers and brands.

Unlike traditional agencies that are "siloed" or structured by discipline, MicroMass brings together under one roof the expertise and services for building sophisticated, multi-channel programs that span the full relationship marketing continuum.

Headquartered in Cary, N.C., with a second office in Morristown, N.J., MicroMass is one of the fastest growing agencies in its field. With experience in more than 30 therapeutic categories, MicroMass has a roster of clients that includes GlaxoSmithKline, Johnson & Johnson, LabCorp, Merck & Co., Inc., Novartis, Shire and UCB Pharma.

For additional information on MicroMass, visit www.micromass.com.

    CONTACT:  Julie Laitin (212) 286-2424       Cynthia Amorese (908) 665-8072
              Email: jlaitin@julielaitin.com    Email: camorese@comcast.net


'/>"/>
SOURCE MicroMass Communications, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Dakim Campaign Promotes Brain Fitness for Seniors with Elderly Holding Signs Declaring My Brain Is Not Retired
2. Indoor Tanning Association Promotes Responsible Tanning for Spring Breakers
3. Telehealth for diabetes promotes aging at home, not in the hospital
4. Medical Disposables Promotes Jennifer Munoz as Vice President of Marketing
5. Availity Promotes Russ Thomas to President and Chief Operating Officer
6. Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
7. MedVance Institute Promotes John L. Hopkins to Chairman of the Board of Directors
8. World-Renowned Golf Instructor David Leadbetter Promotes VaNu
9. SOBeFiT Magazine Promotes its Launch With First Annual 5K Run+Walk & Fitness Festival in South Beach
10. Turning down gene expression promotes nerve cell maintenance
11. DaVita.com Promotes Kidney-Friendly Foods for Super Bowl(R) XLIII
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: